Latest Factsheet and Blog

Intl. Biotechnology Trust PLC
02 August 2024
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

IBT's factsheet for the month ended 30 June 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.

 

In recent IBT blog posts, we've highlighted the improving outlook for the biotechnology sector, noting the gradual improvement in the quality of companies within the industry. Here, we delve into the accelerating innovation and increased availability of finance in the biotechnology sector and examine how these factors are shaping the outlook for investors.

 

In recent IBT blog posts, we have alluded to the improving outlook for the biotechnology sector, and how the quality of the companies in the sector is gradually improving. Here we take a look at the accelerating innovation and availability of finance in the biotechnology sector, and how they are influencing the outlook for investors.

 

The blog can be read here:

 

https://schro.link/ibt-blog-july-24

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited

 

Kirsty Preston (PR)

 

Kerry Higgins (Company Secretary)                  

 

 

020 7658 6000

 

020 7658 6000

 

 

Kaso Legg Communications (Financial PR)

 

Charles Gorman                      

Henry Taylor

Effie Aye Maung Hider

 

IBT@kl-communications.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings